Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

Erin R Aho1, Jing Wang2, Rocco D Gogliotti3

  • 1Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Cell Reports
|March 14, 2019
PubMed

Insights

WIN site inhibitors block the chromatin protein WDR5, impacting cancer-related ribosome genes. This leads to reduced protein production and may offer new cancer treatment strategies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Pharmacology

Background:

  • The chromatin-associated protein WDR5 is a key target for cancer drug development.
  • Current drug discovery focuses on inhibiting the WDR5 WIN site, but the precise WDR5 target genes and inhibitor effects are not fully understood.

Purpose of the Study:

  • To investigate the role of the WDR5 WIN site in chromatin association and gene regulation.
  • To elucidate the primary effects of WIN site inhibitors in cancer contexts.

Main Methods:

  • Discovery and application of potent small molecule WIN site inhibitors.
  • Analysis of WDR5 chromatin binding and gene expression changes.
  • Assessment of downstream cellular effects including translation, nucleolar stress, and p53 induction.

Main Results:

  • The WDR5 WIN site was found to link WDR5 to a specific set of chromatin loci, including ribosome protein genes.
  • WIN site inhibitors rapidly displaced WDR5 from chromatin and decreased target gene expression.
  • Inhibitor treatment resulted in translational inhibition, nucleolar stress, and p53 activation.

Conclusions:

  • WDR5 engages chromatin via its WIN site, regulating a specific cohort of genes.
  • WIN site blockade effectively inhibits WDR5 function, leading to cancer-relevant cellular responses.
  • Targeting the WDR5 WIN site shows promise for treating various cancer types.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Electron Affinity03:07

Electron Affinity

The electron affinity (EA) is the energy change for adding an electron to a gaseous atom to form an anion (negative ion).
43.2K
Chromatin Packaging02:21

Chromatin Packaging

Each human somatic cell contains 6 billion base-pairs of DNA. Each base-pair is 0.34 nm long, which means that each diploid cell contains a staggering 2 meters of DNA. How is such a long DNA strand packed inside a nucleus measuring only 10 - 20 microns in diameter? 
The chromatin
In combination with specialized DNA binding protein called Histones, the DNA double helix forms a compact DNA: protein complex called chromatin. The chromatin itself is further compacted into higher-order...
22.0K
Affinity and Avidity01:41

Affinity and Avidity

Overview
38.7K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
9.4K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.5K